AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.200
+0.020 (0.92%)
At close: Jul 17, 2026, 4:00 PM EDT
2.240
+0.040 (1.82%)
After-hours: Jul 17, 2026, 7:49 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $218.24 million as of July 17, 2026. Its market cap has increased by 5.53% in one year.
Market Cap
218.24M
Enterprise Value
130.36M
1-Year Change
5.53%
Ranking
Category
Stock Price
$2.20
ChartMarket Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $218.24M, a decrease of -74.84%. That is a compound annual growth rate of -13.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 223.80M | -29.36% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 253.27M |
| Sol-Gel Technologies | 246.45M |
| Entrada Therapeutics | 245.03M |
| ProQR Therapeutics | 239.91M |
| Fulcrum Therapeutics | 239.21M |
| Adagene | 238.52M |
| Invivyd | 235.92M |
| Camp4 Therapeutics | 231.07M |